Changes in laboratory results under DAA therapy and during follow-up in patients on the liver transplant waiting list.

Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustement.

Ravaioli, M
Masetti, Michele
Ridolfi, L
Capelli, M
Grazi, Gl
Venturoli, N
DI BENEDETTO, Fabrizio
Bianchi, Fb
Cavrini, G
Faenza, S
Begliomini, B
Pinna, Ad
Gerunda, Giorgio Enrico
Ballardini, G.

January 2007

BACKGROUND: The use of the Model for End-Stage Liver Disease (MELD) score to prioritize patients on ...

Clinical status of patients with abnormal liver function during anti-TNF therapy.

Ying-Ming Chiu (3181272)
Mei-Shu Lai (215894)
K. Arnold Chan (508228)

April 2018

Clinical status of patients with abnormal liver function during anti-TNF therapy.</p

Impact of Different Creatinine Measurement Methods on Liver Transplant Allocation

Kaiser Thorsten
Kinny-Köster Benedict
Bartels Michael
Parthaune Tanja
Schmidt Michael
Thiery Joachim

February 2014

The model for end-stage liver disease (MELD) score is used in many countries to prioritize organ all...

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation - Fig 3

Julia M. Grottenthaler (5345897)
Christoph R. Werner (483015)
Martina Steurer (5345891)
Ulrich Spengler (205545)
Thomas Berg (186372)
Cornelius Engelmann (3857854)
Heiner Wedemeyer (32361)
Thomas von Hahn (345025)
Wolfgang Stremmel (46931)
Anita Pathil (3097575)
Ulrich Seybold (5345894)
Eckart Schott (320945)
Usha Blessin (5345888)
Christoph Sarrazin (48298)
Martin-Walter Welker (333015)
Ellen Harrer (5345885)
Stefan Scholten (210941)
Clemens Hinterleitner (5345900)
Ulrich M. Lauer (214418)
Nisar P. Malek (127224)
Christoph P. Berg (483018)

June 2018

(A) Changes of MELD scores in patients on the liver transplant waiting list. Changes did n...

Hematological and biochemical changes over the course of treatment and during follow up.

Ahmed Nagaty (4494688)
Ekram W. Abd El-Wahab (3345380)

October 2017

Hematological and biochemical changes over the course of treatment and during follow up.</p

Results of the tests of within-subjects effects on biomarkers and time in living donor liver transplantation with hepatocellular carcinoma recurrence.

King-Wah Chiu (322977)
Toshiaki Nakano (27092)
Kuang-Den Chen (322973)
Li-Wen Hsu (322964)
Chia-Yun Lai (322960)
Ching-Yin Huang (443521)
Yu-Fan Cheng (167216)
Shigeru Goto (322962)
Chao-Long Chen (322349)

May 2015

a: computed using alpha = 0.05Results of the tests of within-subjects effects o...

Modifications of liver disease stage following DAA treatment in patients with cirrhosis.

Loreta A. Kondili (3801154)
Giovanni Battista Gaeta (3801163)
Maurizia Rossana Brunetto (650671)
Alfredo Di Leo (136947)
Andrea Iannone (3801151)
Teresa Antonia Santantonio (4491700)
Adele Giammario (4491688)
Giovanni Raimondo (3801157)
Roberto Filomia (3801166)
Carmine Coppola (2577067)
Daniela Caterina Amoruso (4491691)
Pierluigi Blanc (4491706)
Barbara Del Pin (4491703)
Liliana Chemello (4491697)
Luisa Cavalletto (4491676)
Filomena Morisco (398231)
Laura Donnarumma (4491679)
Maria Grazia Rumi (554616)
Antonio Gasbarrini (2626756)
Massimo Siciliano (4033715)
Marco Massari (42328)
Romina Corsini (2107399)
Barbara Coco (650674)
Salvatore Madonia (4491694)
Marco Cannizzaro (4491712)
Anna Linda Zignego (374861)
Monica Monti (409085)
Francesco Paolo Russo (3801145)
Alberto Zanetto (3801148)
Marcello Persico (4060159)
Mario Masarone (4060147)
Erica Villa (136943)
Veronica Bernabucci (136963)
Gloria Taliani (440231)
Elisa Biliotti (440233)
Luchino Chessa (844429)
Maria Cristina Pasetto (844444)
Pietro Andreone (418111)
Marzia Margotti (4491709)
Giuseppina Brancaccio (648640)
Donatella Ieluzzi (485177)
Guglielmo Borgia (3556868)
Emanuela Zappulo (4491685)
Vincenza Calvaruso (441341)
Salvatore Petta (113995)
Loredana Falzano (326287)
Maria Giovanna Quaranta (346606)
Liliana Elena Weimer (3801169)
Stefano Rosato (4491682)
Stefano Vella (235926)
Edoardo Giovanni Giannini (4491673)

October 2017

(A) Baseline, post-failure and post-retreatment SVR12 changes of Child Pugh Class; (B) baseline a...

Results of follow-up of 29 MYH9-RD patients with alterations of liver enzymes.

Alessandro Pecci (325142)
Ginevra Biino (123824)
Tiziana Fierro (325144)
Valeria Bozzi (325147)
Annamaria Mezzasoma (325149)
Patrizia Noris (325150)
Ugo Ramenghi (84557)
Giuseppe Loffredo (325152)
Fabrizio Fabris (325153)
Stefania Momi (325154)
Umberto Magrini (325155)
Mario Pirastu (175088)
Anna Savoia (325156)
Carlo Balduini (325157)
Paolo Gresele (325158)

February 2013

Results of follow-up of 29 MYH9-RD patients with alterations of liver enzymes.</p

HCV-RNA levels pre- and post-LT.

Catarina Skoglund (6392237)
Martin Lagging (321589)
Maria Castedal (4500178)

February 2019

The individual HCV RNA levels at start of DAA-therapy, at the day of liver transplantation as well a...

Haemodinamic changes in living-related liver transplant: a colour-doppler ultrasound study. .

BERTANI H
CREMONINI C
DEL BUONO MG
PRIMERANO A
CAUTERO N
GELMINI, Roberta
JOVINE, Elio
PINNA, Antonio Daniele
MANENTI, Federico
VILLA, Erica

January 2002

Haemodinamic changes in living-related liver transplant: a colour-doppler ultrasound stud

Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.

Belli LS
Perricone G
Adam R
Cortesi PA
Strazzabosco M
Facchetti R
Karam V
Salizzoni M
Andujar RL
Fondevila C
De Simone P
Morelli C
Fabregat-Prous J
Samuel D
Agarwaal K
Moreno Gonzales E
Charco R
Zieniewicz K
De Carlis L
Duvoux C

January 2018

BACKGROUND & AIMS: Direct-acting antivirals (DAAs) have dramatically improved the outcome of patien...

Changes in serum cytokine levels between preoperative day 1 and postoperative day 7 in patients undergoing living donor liver transplantation.

Min Suk Chae (5094896)
Kwang Uck Moon (5094890)
Hyun Sik Chung (5094899)
Chul Soo Park (785758)
Jaemin Lee (509885)
Jong Ho Choi (5094893)
Sang Hyun Hong (3005712)

April 2018

Changes in serum cytokine levels between preoperative day 1 and postoperative day 7 in patients u...

Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment

RAVAIOLI, MATTEO
Masetti M
Ridolfi L
CAPELLI, MAURIZIO
GRAZI, GIAN LUCA
VENTUROLI, NICOLA
Di Benedetto F
BIANCHI, FRANCESCO BIANCO
CAVRINI, GIULIA
FAENZA, STEFANO
Begliomini B
PINNA, ANTONIO DANIELE
Gerunda GE
Ballardini G.

January 2007

BACKGROUND. The use of the Model for End-Stage Liver Disease (MELD) score to prioritize patients on ...

Changes in serum creatinine (LS mean ± SE) at various time points after liver transplantation in the non-AKI and AKI group.

Lidia Lewandowska (640861)
Joanna Matuszkiewicz-Rowińska (640862)
Calpurnia Jayakumar (341127)
Urszula Oldakowska-Jedynak (640863)
Stephen Looney (237505)
Michalina Galas (640864)
Małgorzata Dutkiewicz (640865)
Marek Krawczyk (107304)
Ganesan Ramesh (341131)

October 2014

*p≤0.0001 for differences between groups by repeated measures ANOVA.</p

Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy

Flemming, Jennifer A
Kim, W Ray
Brosgart, Carol L
Terrault, Norah A

March 2017

Direct-acting antiviral (DAA) therapy, recently approved for patients with decompensated cirrhosis (...

Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustement.

Ravaioli, M
Masetti, Michele
Ridolfi, L
Capelli, M
Grazi, Gl
Venturoli, N
DI BENEDETTO, Fabrizio
Bianchi, Fb
Cavrini, G
Faenza, S
Begliomini, B
Pinna, Ad
Gerunda, Giorgio Enrico
Ballardini, G.

January 2007

BACKGROUND: The use of the Model for End-Stage Liver Disease (MELD) score to prioritize patients on ...

Clinical status of patients with abnormal liver function during anti-TNF therapy.

Ying-Ming Chiu (3181272)
Mei-Shu Lai (215894)
K. Arnold Chan (508228)

April 2018

Clinical status of patients with abnormal liver function during anti-TNF therapy.</p

Impact of Different Creatinine Measurement Methods on Liver Transplant Allocation

Kaiser Thorsten
Kinny-Köster Benedict
Bartels Michael
Parthaune Tanja
Schmidt Michael
Thiery Joachim

February 2014

The model for end-stage liver disease (MELD) score is used in many countries to prioritize organ all...

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation - Fig 3

Julia M. Grottenthaler (5345897)
Christoph R. Werner (483015)
Martina Steurer (5345891)
Ulrich Spengler (205545)
Thomas Berg (186372)
Cornelius Engelmann (3857854)
Heiner Wedemeyer (32361)
Thomas von Hahn (345025)
Wolfgang Stremmel (46931)
Anita Pathil (3097575)
Ulrich Seybold (5345894)
Eckart Schott (320945)
Usha Blessin (5345888)
Christoph Sarrazin (48298)
Martin-Walter Welker (333015)
Ellen Harrer (5345885)
Stefan Scholten (210941)
Clemens Hinterleitner (5345900)
Ulrich M. Lauer (214418)
Nisar P. Malek (127224)
Christoph P. Berg (483018)

June 2018

(A) Changes of MELD scores in patients on the liver transplant waiting list. Changes did n...

Hematological and biochemical changes over the course of treatment and during follow up.

Ahmed Nagaty (4494688)
Ekram W. Abd El-Wahab (3345380)

October 2017

Hematological and biochemical changes over the course of treatment and during follow up.</p

Results of the tests of within-subjects effects on biomarkers and time in living donor liver transplantation with hepatocellular carcinoma recurrence.

King-Wah Chiu (322977)
Toshiaki Nakano (27092)
Kuang-Den Chen (322973)
Li-Wen Hsu (322964)
Chia-Yun Lai (322960)
Ching-Yin Huang (443521)
Yu-Fan Cheng (167216)
Shigeru Goto (322962)
Chao-Long Chen (322349)

May 2015

a: computed using alpha = 0.05Results of the tests of within-subjects effects o...

Modifications of liver disease stage following DAA treatment in patients with cirrhosis.

Loreta A. Kondili (3801154)
Giovanni Battista Gaeta (3801163)
Maurizia Rossana Brunetto (650671)
Alfredo Di Leo (136947)
Andrea Iannone (3801151)
Teresa Antonia Santantonio (4491700)
Adele Giammario (4491688)
Giovanni Raimondo (3801157)
Roberto Filomia (3801166)
Carmine Coppola (2577067)
Daniela Caterina Amoruso (4491691)
Pierluigi Blanc (4491706)
Barbara Del Pin (4491703)
Liliana Chemello (4491697)
Luisa Cavalletto (4491676)
Filomena Morisco (398231)
Laura Donnarumma (4491679)
Maria Grazia Rumi (554616)
Antonio Gasbarrini (2626756)
Massimo Siciliano (4033715)
Marco Massari (42328)
Romina Corsini (2107399)
Barbara Coco (650674)
Salvatore Madonia (4491694)
Marco Cannizzaro (4491712)
Anna Linda Zignego (374861)
Monica Monti (409085)
Francesco Paolo Russo (3801145)
Alberto Zanetto (3801148)
Marcello Persico (4060159)
Mario Masarone (4060147)
Erica Villa (136943)
Veronica Bernabucci (136963)
Gloria Taliani (440231)
Elisa Biliotti (440233)
Luchino Chessa (844429)
Maria Cristina Pasetto (844444)
Pietro Andreone (418111)
Marzia Margotti (4491709)
Giuseppina Brancaccio (648640)
Donatella Ieluzzi (485177)
Guglielmo Borgia (3556868)
Emanuela Zappulo (4491685)
Vincenza Calvaruso (441341)
Salvatore Petta (113995)
Loredana Falzano (326287)
Maria Giovanna Quaranta (346606)
Liliana Elena Weimer (3801169)
Stefano Rosato (4491682)
Stefano Vella (235926)
Edoardo Giovanni Giannini (4491673)

October 2017

(A) Baseline, post-failure and post-retreatment SVR12 changes of Child Pugh Class; (B) baseline a...

Results of follow-up of 29 MYH9-RD patients with alterations of liver enzymes.

Alessandro Pecci (325142)
Ginevra Biino (123824)
Tiziana Fierro (325144)
Valeria Bozzi (325147)
Annamaria Mezzasoma (325149)
Patrizia Noris (325150)
Ugo Ramenghi (84557)
Giuseppe Loffredo (325152)
Fabrizio Fabris (325153)
Stefania Momi (325154)
Umberto Magrini (325155)
Mario Pirastu (175088)
Anna Savoia (325156)
Carlo Balduini (325157)
Paolo Gresele (325158)

February 2013

Results of follow-up of 29 MYH9-RD patients with alterations of liver enzymes.</p

HCV-RNA levels pre- and post-LT.

Catarina Skoglund (6392237)
Martin Lagging (321589)
Maria Castedal (4500178)

February 2019

The individual HCV RNA levels at start of DAA-therapy, at the day of liver transplantation as well a...

Haemodinamic changes in living-related liver transplant: a colour-doppler ultrasound study. .

BERTANI H
CREMONINI C
DEL BUONO MG
PRIMERANO A
CAUTERO N
GELMINI, Roberta
JOVINE, Elio
PINNA, Antonio Daniele
MANENTI, Federico
VILLA, Erica

January 2002

Haemodinamic changes in living-related liver transplant: a colour-doppler ultrasound stud

Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.

Belli LS
Perricone G
Adam R
Cortesi PA
Strazzabosco M
Facchetti R
Karam V
Salizzoni M
Andujar RL
Fondevila C
De Simone P
Morelli C
Fabregat-Prous J
Samuel D
Agarwaal K
Moreno Gonzales E
Charco R
Zieniewicz K
De Carlis L
Duvoux C

January 2018

BACKGROUND & AIMS: Direct-acting antivirals (DAAs) have dramatically improved the outcome of patien...

Changes in serum cytokine levels between preoperative day 1 and postoperative day 7 in patients undergoing living donor liver transplantation.

Min Suk Chae (5094896)
Kwang Uck Moon (5094890)
Hyun Sik Chung (5094899)
Chul Soo Park (785758)
Jaemin Lee (509885)
Jong Ho Choi (5094893)
Sang Hyun Hong (3005712)

April 2018

Changes in serum cytokine levels between preoperative day 1 and postoperative day 7 in patients u...

Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment

RAVAIOLI, MATTEO
Masetti M
Ridolfi L
CAPELLI, MAURIZIO
GRAZI, GIAN LUCA
VENTUROLI, NICOLA
Di Benedetto F
BIANCHI, FRANCESCO BIANCO
CAVRINI, GIULIA
FAENZA, STEFANO
Begliomini B
PINNA, ANTONIO DANIELE
Gerunda GE
Ballardini G.

January 2007

BACKGROUND. The use of the Model for End-Stage Liver Disease (MELD) score to prioritize patients on ...

Changes in serum creatinine (LS mean ± SE) at various time points after liver transplantation in the non-AKI and AKI group.

Lidia Lewandowska (640861)
Joanna Matuszkiewicz-Rowińska (640862)
Calpurnia Jayakumar (341127)
Urszula Oldakowska-Jedynak (640863)
Stephen Looney (237505)
Michalina Galas (640864)
Małgorzata Dutkiewicz (640865)
Marek Krawczyk (107304)
Ganesan Ramesh (341131)

October 2014

*p≤0.0001 for differences between groups by repeated measures ANOVA.</p

Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy

Flemming, Jennifer A
Kim, W Ray
Brosgart, Carol L
Terrault, Norah A

March 2017

Direct-acting antiviral (DAA) therapy, recently approved for patients with decompensated cirrhosis (...

Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustement.

Ravaioli, M
Masetti, Michele
Ridolfi, L
Capelli, M
Grazi, Gl
Venturoli, N
DI BENEDETTO, Fabrizio
Bianchi, Fb
Cavrini, G
Faenza, S
Begliomini, B
Pinna, Ad
Gerunda, Giorgio Enrico
Ballardini, G.

January 2007

BACKGROUND: The use of the Model for End-Stage Liver Disease (MELD) score to prioritize patients on ...

Clinical status of patients with abnormal liver function during anti-TNF therapy.

Ying-Ming Chiu (3181272)
Mei-Shu Lai (215894)
K. Arnold Chan (508228)

April 2018

Clinical status of patients with abnormal liver function during anti-TNF therapy.</p

Impact of Different Creatinine Measurement Methods on Liver Transplant Allocation

Kaiser Thorsten
Kinny-Köster Benedict
Bartels Michael
Parthaune Tanja
Schmidt Michael
Thiery Joachim

February 2014

The model for end-stage liver disease (MELD) score is used in many countries to prioritize organ all...

Changes in laboratory results under DAA therapy and during follow-up in patients on the liver transplant waiting list.

Abstract

Extracted data

Changes in laboratory results under DAA therapy and during follow-up in patients on the liver transplant waiting list.

Abstract

Extracted data

Related items

Related items